Search

Akm E. Ullah

Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )

Most Active Art Unit
2874
Art Unit(s)
2874, 2606, 2501, 1734, 2899, 3621, 2838
Total Applications
3400
Issued Applications
3065
Pending Applications
95
Abandoned Applications
245

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6486393 [patent_doc_number] => 20020152493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005467 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20413 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20020152493.pdf [firstpage_image] =>[orig_patent_app_number] => 10005467 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/005467
Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions Dec 3, 2001 Abandoned
Array ( [id] => 6557975 [patent_doc_number] => 20020194636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Transgenic mice containing polycystin-related gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005211 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20316 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20020194636.pdf [firstpage_image] =>[orig_patent_app_number] => 10005211 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/005211
Transgenic mice containing polycystin-related gene disruptions Dec 3, 2001 Abandoned
Array ( [id] => 5927039 [patent_doc_number] => 20020116729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Transgenic mice containing NTTP1 phosphatase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005858 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19831 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20020116729.pdf [firstpage_image] =>[orig_patent_app_number] => 10005858 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/005858
Transgenic mice containing NTTP1 phosphatase gene disruptions Dec 3, 2001 Abandoned
Array ( [id] => 5985160 [patent_doc_number] => 20020098223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Biocompatible implant for the expression and in vivo secretion of a therapeutic substance' [patent_app_type] => new [patent_app_number] => 09/987601 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11718 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098223.pdf [firstpage_image] =>[orig_patent_app_number] => 09987601 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/987601
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance Nov 14, 2001 Abandoned
Array ( [id] => 6861092 [patent_doc_number] => 20030092100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Tn7 transposition method for producing mutant genes' [patent_app_type] => new [patent_app_number] => 10/010288 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8977 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092100.pdf [firstpage_image] =>[orig_patent_app_number] => 10010288 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/010288
Tn7 transposition method for producing mutant genes Nov 12, 2001 Abandoned
10/009445 Ox2 receptor homologs Nov 12, 2001 Abandoned
Array ( [id] => 5927040 [patent_doc_number] => 20020116730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Transgenic mice containing PERK protein kinase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005983 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20009 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20020116730.pdf [firstpage_image] =>[orig_patent_app_number] => 10005983 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/005983
Transgenic mice containing PERK protein kinase gene disruptions Nov 6, 2001 Abandoned
Array ( [id] => 6683323 [patent_doc_number] => 20030119187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Antigen presenting cells, method for their preparation and their use for cancer vaccines' [patent_app_type] => new [patent_app_number] => 09/981239 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10033 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119187.pdf [firstpage_image] =>[orig_patent_app_number] => 09981239 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/981239
Antigen presenting cells, method for their preparation and their use for cancer vaccines Oct 17, 2001 Abandoned
Array ( [id] => 6086143 [patent_doc_number] => 20020083481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Vectors and methods for the mutagenesis of mammalian genes' [patent_app_type] => new [patent_app_number] => 09/982586 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8867 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20020083481.pdf [firstpage_image] =>[orig_patent_app_number] => 09982586 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/982586
Vectors and methods for the mutagenesis of mammalian genes Oct 16, 2001 Abandoned
Array ( [id] => 5828214 [patent_doc_number] => 20020068274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Novel method for assessing recoding in vitro and in vivo' [patent_app_type] => new [patent_app_number] => 09/981393 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11755 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068274.pdf [firstpage_image] =>[orig_patent_app_number] => 09981393 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/981393
Novel method for assessing recoding in vitro and in vivo Oct 15, 2001 Abandoned
Array ( [id] => 1053441 [patent_doc_number] => 06858772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions' [patent_app_type] => utility [patent_app_number] => 09/972741 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20390 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858772.pdf [firstpage_image] =>[orig_patent_app_number] => 09972741 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/972741
Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions Oct 4, 2001 Issued
Array ( [id] => 1275807 [patent_doc_number] => 06637366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Nematode biopesticide' [patent_app_type] => B1 [patent_app_number] => 09/869080 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4058 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/637/06637366.pdf [firstpage_image] =>[orig_patent_app_number] => 09869080 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/869080
Nematode biopesticide Sep 30, 2001 Issued
09/868310 In vivo odontogenic model using rodent's mandibular incisor Sep 30, 2001 Abandoned
Array ( [id] => 5971866 [patent_doc_number] => 20020092034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Non-human model of gestational and adult folate deficiency and uses thereof' [patent_app_type] => new [patent_app_number] => 09/962290 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14923 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20020092034.pdf [firstpage_image] =>[orig_patent_app_number] => 09962290 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/962290
Non-human model of gestational and adult folate deficiency and uses thereof Sep 23, 2001 Abandoned
Array ( [id] => 6175586 [patent_doc_number] => 20020155421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Endothelial cell mitogen bioassay' [patent_app_type] => new [patent_app_number] => 09/961128 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155421.pdf [firstpage_image] =>[orig_patent_app_number] => 09961128 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/961128
Endothelial cell mitogen bioassay Sep 20, 2001 Abandoned
Array ( [id] => 6861175 [patent_doc_number] => 20030092183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Rapid creation of gene targeting vectors using homologous recombination in yeast' [patent_app_type] => new [patent_app_number] => 09/961163 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11391 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092183.pdf [firstpage_image] =>[orig_patent_app_number] => 09961163 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/961163
Rapid creation of gene targeting vectors using homologous recombination in yeast Sep 20, 2001 Abandoned
Array ( [id] => 6711089 [patent_doc_number] => 20030170838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Novel polynucleotides and polypeptides encoded thereby' [patent_app_type] => new [patent_app_number] => 09/954342 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70761 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170838.pdf [firstpage_image] =>[orig_patent_app_number] => 09954342 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/954342
Novel polynucleotides and polypeptides encoded thereby Sep 16, 2001 Abandoned
Array ( [id] => 1068630 [patent_doc_number] => 06844156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Methods for identifying a preferred liver transplant donor' [patent_app_type] => utility [patent_app_number] => 09/955407 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7938 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844156.pdf [firstpage_image] =>[orig_patent_app_number] => 09955407 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/955407
Methods for identifying a preferred liver transplant donor Sep 11, 2001 Issued
Array ( [id] => 1181358 [patent_doc_number] => 06740793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-25 [patent_title] => 'Transgenic animal having a disrupted PDE7A gene and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/950920 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11972 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740793.pdf [firstpage_image] =>[orig_patent_app_number] => 09950920 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/950920
Transgenic animal having a disrupted PDE7A gene and uses thereof Sep 11, 2001 Issued
Array ( [id] => 1171059 [patent_doc_number] => 06753456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-22 [patent_title] => 'Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety' [patent_app_type] => B2 [patent_app_number] => 09/949298 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 12560 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753456.pdf [firstpage_image] =>[orig_patent_app_number] => 09949298 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/949298
Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety Sep 6, 2001 Issued
Menu